Heuron co., Ltd. is an AI-based medical imaging and diagnostic solutions for Neurodegenerative disease including Parkinson's disease, Alzheimer's disease, stroke, and brain tumor. Heuron is on a mission to transform current complex diagnostic challenges into simple solutions with innovative technology. The company was founded by a Neurologist with 15 years of experience.

Sunnybrook Research Institute (SRI) is the research component of Sunnybrook Health Sciences Centre in Toronto, Ontario. It is one of the largest research centres in Canada and is fully affiliated with the University of Toronto. The institute employs over 300 scientists and clinician-scientists and has a total of over 1300 research staff.

Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several cancer indications. The Company has developed a highly specific PET (Positron emission tomography) imaging ligand, uTRACE®, targeting the receptor uPAR, which is a biomarker only expressed in cancer. uTRACE® will become a game-changer in the diagnosis and treatment of cancer patients. In addition, with the promising results obtained within diagnostics Curasight will also pursues uPAR targeted radionuclide therapy using the uTREAT® ligand. As PET imaging and radionuclide therapy is based on the same uPAR binding peptide, a uTRACE® scan can precisely predict where subsequent targeted radiation therapy will be delivered. uTRACE® covers the diagnostic path and uTREAT® covers the therapy. This will be the new management and treatment of cancer patients in the future.

Rigshospitalet (meaning The National, State or Kingdom Hospital, but not usually translated) is one of the largest hospitals in Denmark and the most highly specialised hospital in Copenhagen. The hospital's main building is a 16 storey functionalist highrise, one of the tallest structures in the central parts of the city. Rigshospitalet neighbours the Panum Building which houses the Faculty of Health and Medical Sciences at the University of Copenhagen. As a teaching hospital it is part of the framework organisation Copenhagen University Hospital.

Tempus Labs, Inc. enagegs in the development of a platform that analyzes clinical and molecular data points focusing on cancer research. It connects physicians treatment options and relevant insights for patients based on their unique molecular profile and analytics and machine-learning algorithms. The firm offers genomic sequencing, clinical data structuring, image recognition, biological modeling, and time trial program. The company was founded by Bradley A. Keywell and Eric P. Lefkofsky in 2015 and is headquartered in Chicago, IL.

Manufactures healthcare equipment

Quibim, with headquarters in Valencia, Spain, is a global leader in whole-body medical imaging analysis. Quibim products are used worldwide by leading pharmaceutical companies and research teams. Partners use Quibim Precision®, a whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of novel treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers. We understand every body part. We speak human.

Biogen International Neuroscience GmbH, part of Biogen, Inc., is a Swiss company located in Schlieren that manufactures biopharmaceutical products. Biogen, Inc. acquired Biogen International Neuroscience GmbH from Neurimmune Holding AG on December 17, 2010 for $427.50 million.

Bard Peripheral Vascular, Inc., a subsidiary of Becton, Dickinson & Co., is an American company located in Tempe, AZ. The firm provides surgical and interventional devices for peripheral vascular patency.

T-Mobile USA, Inc. engages in the provision of wireless voice, messaging, and data services. It offers different plans for phones and tablets. The company was founded by John W. Stanton in 1994 and is headquartered in Bellevue, WA.

Minerva Imaging provides services for translational cancer research and drug development. Their services include oncology, radionuclide therapy, molecular imaging, and cardiovascular disease. They respond to customer inquiries by phone, contact form, and email.

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, cancer screening, and clinical practice. The company standardizes and automates the interpretation of medical images in oncology to optimize the diagnosis of cancer patients and the assessment of their response to therapy. The company serves two primary markets: drug development and patient care. MEDIAN Technologies has a strategic partnership with a contract research organization to offer integrated imaging services for clinical trials to biopharma sponsors worldwide, and a strategic partnership with Canon to develop new imaging technologies, and to address the patient care market. MEDIAN Technologies was founded in 2002 and is based in Sophia-Antipolis, France.

Human Longevity (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. Its business areas include the HLI Health Nucleus, a genomic powered clinical research center that uses whole-genome sequence analysis, advanced clinical imaging, and innovative machine learning, along with curated personal health information to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. It was founded in 2013 and is headquartered in San Diego, California.

Hologic engages in the development, manufacture, and supply of medical imaging systems and diagnostic and surgical products focused on the healthcare needs of women. Products The company operates in four segments: Breast Health; Diagnostics; GYN Surgical; and Skeletal Health. BREAST HEALTH PRODUCTS The company's breast health business offers a line of breast imaging products, including the Selenia full field digital mammography system, a series of screen-film mammography systems, breast biopsy image guidance systems, computer-aided detection (CAD) systems for both screen-film and digital mammography, and DirectRay digital detectors. Its breast health business also includes its Interventional Breast Solutions family of products including breast biopsy devices, its MammoSite radiation therapy system and the MammoPad breast cushion. The company's photoconductor coating business, which it acquired in connection with its acquisition of its selenium coating capabilities for its digital detectors, is also a component of its breast health business. DirectRay Digital Detector: The company's DirectRay flat panel detector technology employs an amorphous selenium (a-Se) photoconductor to directly convert x-ray photons into an electrical signal. Selenia Full Field Digital Mammography System: The Selenia full field digital mammography system is based on its proprietary, amorphous selenium DirectRay digital detector, which preserves image quality by using amorphous selenium to directly convert x-rays to electronic signals, without first converting them to light. This direct conversion process preserves image sharpness by eliminating light diffusion.